Salvage Surgery in the Management of Esophageal Cancer

Persistent esophageal cancer after definitive chemoradiotherapy has poorer survival when compared with recurrent cancer, stated an article printed online ahead of print in the Journal of Clinical Oncology.

Researchers assessed the impact of salvage esophagectomy after definitive chemoradiotherapy (SALV) on clinical outcomes in a large multicenter study that included data from consecutive adult patients undergoing resection for esophageal cancer in 30 European centers from 2000 to 2010.

In-hospital mortality was similar between both groups. Significant differences in complications were seen for anastomotic leak (17.2% vs 10.7%), as well as surgical site infection, which was more common in the SALV group.

CancerTherapyAdvisor.com is a free online resource that offers oncology healthcare professionals a comprehensive knowledge base of practical oncology information and clinical tools to assist in making the right decisions for their patients.

Our mission is to provide practice-focused clinical and drug information that is reflective of current and emerging principles of care that will help to inform oncology decisions.